Glucocorticoids, 11β-hydroxysteroid dehydrogenase type 1, and visceral obesity

被引：5
作者：
Paulmyer-Lacroix, O
Boullu-Ciocca, S
Oliver, C
Dutour, A
Grino, M
机构：
[1] Univ Mediterranee, Inst Jean Rochei, UFR Med Secteur Nord, Lab Interact Fonctionnelles, F-13916 Marseille 20, France
[2] Hop Nord Marseille, Serv Endocrinol Malad Metab & Nutr, F-13015 Marseille, France
来源：
M S-MEDECINE SCIENCES | 2003年 / 19卷 / 04期
关键词：
D O I：
10.1051/medsci/2003194473
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Glucocorticoids are implicated as a pathophysiological mediator of obesity and its accompanying metabolic and cardiovascular complications. Obese patients exhibit normal circulating cortisol levels, related to increased glucocorticoid production and degradation. However, it has been demonstrated that local production of active cortisol from inactive cortisone driven by 11beta-hydroxysteroid dehydrogenase type 1 is exaggerated in adipose tissue of obese subjects. Such local hypercortisolism may be responsible for increased adipocyte differentiation and enhanced secretion of free fatty acids and other substances involved in the metabolic and cardiovascular complications observed in obesity.
引用
收藏
页码：473 / 476
页数：4
相关论文
共 20 条
  • [1] Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids
    Bamberger, CM
    Schulte, HM
    Chrousos, GP
    [J]. ENDOCRINE REVIEWS, 1996, 17 (03) : 245 - 261
  • [2] Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat - Evidence of differences between visceral and subcutaneous deposits
    Bastelica, D
    Morange, P
    Berthet, B
    Borghi, H
    Lacroix, O
    Grino, M
    Juhan-Vague, I
    Alessi, MC
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (01) : 173 - 178
  • [3] Peroxisome proliferator-activated receptor-γ ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity
    Berger, J
    Tanen, M
    Elbrecht, A
    Hermanowski-Vosatka, A
    Moller, DE
    Wright, SD
    Thieringer, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) : 12629 - 12635
  • [4] The metabolic syndrome -: a neuroendocrine disorder?
    Björntorp, P
    Rosmond, R
    [J]. BRITISH JOURNAL OF NUTRITION, 2000, 83 : S49 - S57
  • [5] Differentiation of adipose stromal cells:: The roles of glucocorticoids and 11β-hydroxysteroid dehydrogenase
    Bujalska, IJ
    Kumar, S
    Hewison, M
    Stewart, PM
    [J]. ENDOCRINOLOGY, 1999, 140 (07) : 3188 - 3196
  • [6] A switch in dehydrogenase to reductase activity of 11,6-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells
    Bujalska, IJ
    Walker, EA
    Hewison, M
    Stewart, PM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) : 1205 - 1210
  • [7] Does central obesity reflect ''Cushing's disease of the omentum''?
    Bujalska, IJ
    Kumar, S
    Stewart, PM
    [J]. LANCET, 1997, 349 (9060) : 1210 - 1213
  • [8] Resistance to glucocorticoid feedback in obesity
    Jessop, DS
    Dallman, MF
    Fleming, D
    Lightman, SL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (09) : 4109 - 4114
  • [9] An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue
    Katz, JR
    Mohamed-Ali, V
    Wood, PJ
    Yudkin, JS
    Coppack, SW
    [J]. CLINICAL ENDOCRINOLOGY, 1999, 50 (01) : 63 - 68
  • [10] Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes
    Kelly, IE
    Han, TS
    Walsh, K
    Lean, MEJ
    [J]. DIABETES CARE, 1999, 22 (02) : 288 - 293
12